Novozymes A/S
NVZMFOTCBasic Materials● Active
$56.36
$-1.42(-2.45%)
Market Cap$26.3B
P/E Ratio—
52W High$75.97
52W Low$52.1
Novozymes A/S (NVZMF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVZMF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.16B | $3.83B | $17.91B | $17.55B | $14.95B |
| Cost of Revenue | $1.92B | $1.84B | $8.18B | $7.96B | $6.31B |
| Gross Profit | $2.24B | $1.99B | $9.73B | $9.59B | $8.64B |
| Gross Margin %(computed) | 53.91% | 52.00% | 54.32% | 54.63% | 57.78% |
| Operating Expenses | |||||
| R&D Expenses | ($0.06B) | $0.41B | $2.02B | $2.00B | $2.01B |
| G&A Expenses | $0.03B | $0.21B | $0.96B | $0.13B | $0.12B |
| Total Operating Expenses | $1.36B | $1.49B | $5.75B | $5.03B | $4.63B |
| Operating Income | $0.88B | $0.50B | $3.98B | $4.56B | $4.01B |
| Operating Margin %(computed) | 21.23% | 13.07% | 22.21% | 25.98% | 26.80% |
| Interest Income | $0.00B | $0.03B | $0.02B | $0.02B | $0.02B |
| Interest Expense | $0.01B | $0.08B | $0.02B | $0.10B | $0.10B |
| Income Before Tax | $0.74B | $0.42B | $3.91B | $4.56B | $3.92B |
| Income Tax Expense | $0.16B | $0.11B | $0.87B | $0.87B | $0.78B |
| Net Income | $0.58B | $0.31B | $3.03B | $3.68B | $3.15B |
| Net Margin %(computed) | 14.04% | 7.98% | 16.90% | 20.94% | 21.04% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.25 | $0.67 | $10.88 | $13.20 | $11.32 |
| Wtd Avg Shares | 0.41B | 0.46B | 0.28B | 0.28B | 0.28B |
| EBITDA | $1.39B | $1.08B | $5.64B | $5.72B | $5.06B |
| EBITDA Margin %(computed) | 33.35% | 28.23% | 31.51% | 32.59% | 33.85% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more Novozymes A/S data
About Novozymes A/S (NVZMF) Income Statement
Novozymes A/S (NVZMF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NVZMF reported revenue of $4.16B, gross profit of $2.24B (gross margin 53.91%), and net income of $0.58B — a net profit margin of 14.04%.
Frequently asked questions
NVZMF · 4 questionsNovozymes A/S (NVZMF) reported revenue of $4.16B for 2025, up 8.5% year-over-year.
NVZMF revenueNVZMF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09